• BMX Kinase-Driven ATP6V1E1 Phosphorylation in Mtb Survival

  2026-04-25

  This study uncovers how Mycobacterium tuberculosis (Mtb) exploits the host kinase BMX to phosphorylate ATP6V1E1, suppressing lysosomal acidification and promoting bacterial survival. The findings highlight a novel host-pathogen interaction and point to BMX kinase as a potential target for host-directed therapies against tuberculosis.

• PBA-Modified PAD4 Inhibitors: Targeting Tumor NETs with Prec

  2026-04-24

  The referenced study introduces PBA-modified PAD4 inhibitors, notably Compound 5i, that selectively target tumor cells and neutrophils to inhibit histone H3 citrullination and neutrophil extracellular trap (NET) formation. This work demonstrates significant antitumor efficacy in preclinical models by modulating the tumor immune microenvironment, providing new direction for precision inhibitor design.

• Transcription Termination Mitigates DNA Damage Post-WEE1 Inh

  2026-04-24

  This study demonstrates that transcription termination is critical for preventing DNA damage and cell death following WEE1 inhibitor exposure. By dissecting the interplay between transcription-replication conflicts and genome stability, the findings highlight new mechanistic opportunities for cancer therapy.

• Arachidonic Acid Supplementation Enhances Vaccine-Induced Im

  2026-04-23

  This study demonstrates that dietary arachidonic acid (ARA) enhances humoral immune responses to rabies vaccination in mice and humans by promoting the production of neutralizing antibodies. Mechanistic insights reveal a role for ARA-derived prostaglandin I2 in B cell activation, providing a new dietary strategy to improve vaccine efficacy and speed of protection.

• Alda 1 (SKU B5508): Reliable ALDH2 Activation for Cell Assay

  2026-04-23

  This article details how Alda 1 (SKU B5508) from APExBIO provides consistent and data-backed solutions to common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. We explore real-world scenarios where precise ALDH2 activation is critical, highlighting evidence-based protocol optimization and product selection strategies to maximize reproducibility and scientific value.

• Phebestin as an Aminopeptidase Inhibitor for Malaria Therapy

  2026-04-22

  This article analyzes the recent evaluation of phebestin, a bestatin-related aminopeptidase inhibitor, demonstrating its nanomolar efficacy against Plasmodium falciparum and potent activity in resistant malaria models. The study’s findings have significant implications for targeting parasite proteolytic pathways and underscore the need for novel antimalarial agents given rising drug resistance.

• P2RX1 Drives Mitochondrial Apoptosis via CaMKII in Ph+ ALL

  2026-04-22

  Li et al. reveal that P2RX1 overexpression promotes mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by modulating calcium/CaMKII and suppressing PI3K/Akt signaling. These insights suggest P2RX1 as a potential therapeutic target and provide mechanistic clarity for apoptosis pathway interrogation in Ph+ ALL.

• Cy5-UTP: Advancing RNA Labeling for Translational Impact

  2026-04-21

  This thought-leadership article explores how Cy5-UTP (Cyanine 5-uridine triphosphate) is redefining fluorescent RNA labeling for translational research. Blending mechanistic insight, protocol guidance, and competitive benchmarking, it offers strategic recommendations for researchers navigating complex RNA-centric workflows—from mRNA nanovaccine tracking to multiplexed FISH. The discussion bridges foundational findings with clinical ambitions, referencing recent advances in dual immunoregulatory mRNA nanovaccine research for autoimmune disease. We position Cy5-UTP as a linchpin for innovation, highlighting its unique mechanistic value and practical utility as supplied by APExBIO.

• O-GlcNAcylation Drives Wnt-Induced Glycolysis in Bone Format

  2026-04-21

  This study uncovers how O-GlcNAcylation, regulated via Ca2+-PKA-GFAT1 and Wnt–β-catenin pathways, is essential for Wnt-stimulated bone formation by rewiring aerobic glycolysis. The findings provide mechanistic insight into metabolic control of osteogenesis and highlight O-GlcNAcylation as a potential target for bone-anabolic therapies.

• S Tag Peptide (A6007): Practical Guidance for Fusion Tag Wor

  2026-04-20

  S Tag Peptide addresses persistent challenges in recombinant protein detection, purification, and solubility enhancement—especially for proteins prone to aggregation or poor expression. It is most effective when genetically fused to target proteins for downstream affinity-based workflows, but should not be used in applications requiring standalone enzymatic activity or in ethanol-based systems.

• MDV3100 (Enzalutamide): Mechanistic Insights into AR Pathway

  2026-04-20

  Explore how MDV3100 (Enzalutamide) advances prostate cancer research by dissecting androgen receptor signaling and unveiling new resistance mechanisms through glycosaminoglycan biosynthesis. This article delivers in-depth mechanistic analysis, practical assay guidance, and unique integration of the latest reference findings.

• Angiotensin III: Applied Workflows for RAAS and Receptor Stu

  2026-04-19

  Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) is a powerful tool for dissecting the renin-angiotensin-aldosterone system in cardiovascular and neuroendocrine models. This article delivers actionable protocol enhancements, troubleshooting insights, and critical cross-domain analysis, leveraging the latest mechanistic findings and APExBIO’s validated peptide.

• Angiotensin III: Advanced Workflows for RAAS and Viral Resea

  2026-04-18

  Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) uniquely enables rigorous RAAS investigations and emerging viral pathogenesis models. Learn how APExBIO’s high-purity peptide streamlines experimental design, troubleshooting, and cross-domain research with robust, reproducible results.

• 5-Azacytidine for DNA Demethylation: Applied Workflows & Ins

  2026-04-17

  5-Azacytidine (5-AzaC) is transforming epigenetic research through its potent DNA demethylation capabilities, enabling reactivation of silenced genes and induction of cancer cell dormancy. Discover protocol enhancements, practical troubleshooting, and advanced applications—directly informed by recent metastasis research and APExBIO’s rigorously validated compound.

• Tacalcitol Monohydrate Induces NGF in Human Keratinocytes

  2026-04-16

  This study demonstrates that Tacalcitol monohydrate, a synthetic analog of vitamin D3, transcriptionally upregulates nerve growth factor (NGF) production in human epidermal keratinocytes. The findings provide mechanistic insight into NGF regulation in skin, informing both dermatological and neuroprotective research applications.

10145 records 1/677 page Next 12345 下5页 Last page